U.S. Industrials Stock News

NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

Embedded “Pay Later” Loyalty Financing Could Be A Game Changer For JetBlue Airways (JBLU)

In mid-July 2026, JetBlue and ClarityPay launched an embedded “pay later” program that offers eligible customers 0% APR financing for up to 12 months through August 15, 2026, integrated directly into the booking journey with personalized installment options from 6 weeks to 48 months. The program’s tight integration with JetBlue’s TrueBlue loyalty scheme and white-label, AI-driven cross-sell capabilities makes financing a core part of trip planning, potentially deepening customer engagement...
NYSE:TDY
NYSE:TDYElectronic

Should Teledyne’s Record Orders, Higher Guidance and ESOP Shelf Offering Require Action From Teledyne Technologies (TDY) Investors?

Earlier this week, Teledyne Technologies reported Q2 2026 results showing sales of US$1,662.5 million and net income of US$251.7 million, alongside filing a US$651.22 million shelf registration to offer 1,000,000 common shares for an ESOP-related program. The combination of record quarterly orders, higher full-year guidance, and a new employee stock ownership plan offering highlights Teledyne’s focus on both growth and long-term workforce alignment. We’ll now examine how Teledyne’s record...
NYSE:FLS
NYSE:FLSMachinery

Flowserve Stock And 2 Infrastructure Picks Tied To Red Sea Security Risks

Rising tensions in the Red Sea have put critical shipping lanes and energy infrastructure in the spotlight, and that is feeding directly into how investors think about large infrastructure and engineering stocks. When oil routes and key facilities face higher security risks, the companies that build, maintain or secure essential assets can see sentiment shift quickly, for better or worse. This article looks at three stocks from our Global Infrastructure & Engineering Companies screener that...
NYSE:MANU
NYSE:MANUEntertainment

Is A £51m Manu Kone Deal Reshaping The Investment Case For Manchester United (MANU)?

In recent weeks, reports indicate Manchester United have reached an agreement in principle on personal terms with Roma midfielder Manu Kone, as the club intensifies its search for a third midfield signing following departures and injuries. This potential £51m acquisition highlights Manchester United’s commitment to reshaping its midfield core amid strong competition from European and Saudi clubs, reinforcing the club’s effort to build a deeper squad for upcoming campaigns. We’ll now...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

Did ePlus’ (PLUS) Expanded Share Authorization Quietly Redefine Its Capital Flexibility Playbook?

At its 2026 Annual Meeting of Shareholders held on September 10, 2026, ePlus Inc. secured board approval for a proposal to amend its Certificate of Incorporation to lift authorized common shares from 50,000,000 to 75,000,000, keeping preferred shares unchanged at 2,000,000 and raising total authorized capital stock to 77,000,000, subject to shareholder approval. This planned increase in authorized common stock gives ePlus added flexibility to fund future business and financial initiatives,...
NasdaqGS:NSIT
NasdaqGS:NSITElectronic

Insight Enterprises (NSIT) Following AI And Cloud Demand Narrative Faces A Valuation Test

Insight Enterprises (NSIT) has drawn fresh attention after a recent move in its share price, with the stock last closing at $117.65. Investors are weighing this level against the company’s fundamentals and recent return profile. See our latest analysis for Insight Enterprises. The recent 1-day share price return of 1.72% and 90-day share price return of 60.66% place Insight Enterprises firmly in a momentum phase, although the 1-year total shareholder return declined 19.32%, showing a...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Pharmaceuticals (IONS) Trial Setback Sparks Scrutiny, Is The 38% Undervaluation Case Still Credible?

Ionis Pharmaceuticals (IONS) is under renewed scrutiny after reporting that its late stage CARDIO TTRansform trial for eplontersen with AstraZeneca did not meet the primary efficacy endpoint, triggering a sharp share price reaction and a shareholder investigation. See our latest analysis for Ionis Pharmaceuticals. The eplontersen trial failure and shareholder investigation come after a sharp shift in momentum for Ionis Pharmaceuticals, with the share price down 26.10% over 30 days and 29.02%...
NYSE:BROS
NYSE:BROSHospitality

Is Dutch Bros (BROS) Stock Pricey, Or Already Fairly Priced?

Dutch Bros stock has delivered a strong 112.1% total return over the past three years, yet the current checks suggest the shares do not screen as a clear bargain at today’s valuation. Over the last three years, Dutch Bros has returned 112.1%, which puts more weight on whether today’s price already reflects much of that progress. Expectations around sustained store expansion and revenue growth can support the current market price, while any pressure on store level margins or cash generation...
NYSE:BBWI
NYSE:BBWISpecialty Retail

Bath & Body Works (BBWI) Enters Brazil, Is The Stock Undervalued?

Bath & Body Works (BBWI) stock is drawing renewed attention after the company announced its entry into Brazil, opening its first store and digital channel in a market known for strong fragrance and self-care demand. See our latest analysis for Bath & Body Works. At a share price of $19.90, Bath & Body Works has seen its 30-day share price return fall 8.76%, and its 1-year total shareholder return decline 34.43%. This suggests recent momentum has been weak even as investors react to the Brazil...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

Will Korea’s Gigawatt-Scale AI Factories Deal Redefine NVIDIA’s (NVDA) Infrastructure Narrative?

Recently, SK Group and NVIDIA agreed a more than US$500.00 billion AI infrastructure partnership anchored by a planned 2-gigawatt Vera Rubin DSX AI factory, while NAVER, Brookfield and NVIDIA outlined a US$10.00 billion expansion of Korea’s sovereign AI factory footprint and NVIDIA deepened research and packaging ties with KAIST and Amkor. Together, these moves show NVIDIA extending its full-stack AI platform into sovereign and hyperscale “AI factory” builds while simultaneously shoring up...
NYSE:CTRE
NYSE:CTREHealth Care REITs

CareTrust REIT (CTRE) Stock Looks Reasonably Priced With Some Value Left

CareTrust REIT has delivered a strong share price run over the past three years, yet the current checks paint a mixed valuation picture that leaves investors weighing a solid return record against only a partial signal that the stock is still cheap on fundamentals. The stock has returned 137.7% over three years, which puts recent gains at the center of any discussion about whether new buyers are paying up for that performance. Future rent growth and cash flows from its healthcare-focused...
NasdaqCM:FRHC
NasdaqCM:FRHCCapital Markets

Freedom Holding (FRHC) After The Antom Deal With A Pricey 62.7x P E

Freedom Holding (FRHC) drew fresh investor attention after signing Memoranda of Understanding with Antom, a payment services provider under Ant International, to build cross border payment solutions for Kazakhstani users shopping on Chinese e commerce platforms. See our latest analysis for Freedom Holding. At a share price of $151.02, Freedom Holding has pulled back slightly over the last week but still shows a 30 day share price return of 11.49% and a year to date share price return of...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

SS&C Technologies (SSNC) Stock Faces Valuation Debate As EPS Growth Supports Bullish Narratives

SS&C Technologies Holdings (SSNC) has reported a clean set of Q2 2026 numbers, with revenue of US$1.7 billion and basic EPS of US$0.99, alongside trailing 12 month EPS of US$3.58. Over the past few quarters the company has seen revenue move from US$1.54 billion in Q2 2025 to US$1.70 billion in Q2 2026, while basic EPS has risen from US$0.74 to US$0.99. This puts the focus on how a 13.2% trailing net margin shapes the quality of these results for investors. See our full analysis for SS&C...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Alignment Healthcare (ALHC) Stock Looks Below Fair Value After Legal Questions

Alignment Healthcare stock has delivered a very strong 237.9% return over the past three years, yet its valuation checks still suggest the shares screen as cheap rather than stretched. That contrast is now running head on into fresh legal and regulatory questions that could affect how investors think about the quality and sustainability of the company’s earnings. A 237.9% three year gain positions Alignment Healthcare as a major winner over that period, so any hint that its growth story is...
NYSE:HNGE
NYSE:HNGEHealthcare

Pfizer Stock Leads 3 AI Healthcare Names Worth A Closer Look

With markets fixated on geopolitics, energy prices, and shifting inflation signals, many investors are looking for themes tied to long term structural change rather than short term headlines. Artificial intelligence in healthcare sits squarely in that camp, with potential to improve diagnostics, treatment decisions, and productivity across systems facing cost pressure. The Transformative AI Healthcare Stocks screener helps filter companies exposed to this trend, while you keep an eye on macro...
NYSE:BALL
NYSE:BALLPackaging

Ball (BALL) Trades Below Fair Value, Is The Market Still Too Cautious?

Ball (BALL) is drawing fresh attention after recent share price moves, with the stock closing at $63.84 compared with a widely discussed fair value marker of $70.79 that points to a possible valuation gap. See our latest analysis for Ball. Recent moves in Ball's share price, including the 1 day share price return of 2.59% and year to date share price return of 19.66%, come alongside a fair value narrative of $70.79 and a discounted cash flow estimate that points to a potential valuation gap...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Brookfield Infrastructure’s Planned Corporate Simplification and Tax Ease Might Change The Case For Investing In Brookfield Infrastructure Partners (BIP)

In recent days, analysts have reiterated positive views on Brookfield Infrastructure Partners while the company advanced plans to simplify its corporate structure into publicly traded corporations focused on renewable energy and infrastructure, aiming to preserve dividends and ease tax filing for investors. This combination of favorable analyst sentiment and a simplification that could boost liquidity and index inclusion is reshaping how investors evaluate Brookfield Infrastructure Partners...
NYSE:DGX
NYSE:DGXHealthcare

Healthcare Dividend Stocks For Higher Rates With Zimmer Biomet STERIS And Quest

With the Federal Reserve sending mixed signals on future rate cuts and hikes, inflation estimates edging higher, and oil prices reacting to conflict in Iran, many investors are taking a fresh look at large cap defensive dividend stocks. These companies, often in Consumer Staples, Utilities, and Healthcare, are commonly viewed as potential anchors when monetary policy and inflation expectations feel uncertain. This article focuses on how that backdrop connects to our US Large Cap Defensive...
NasdaqGS:AVT
NasdaqGS:AVTElectronic

Avnet (AVT) Stock Still May Be A Bargain On Earnings

Avnet stock has delivered a strong 145.2% return over the past 5 years, yet the company scores poorly on broader valuation checks, leaving investors weighing a solid track record against signals that the shares may not be a simple bargain at the current US$89.42 price. Over 5 years, Avnet has returned 145.2%, which puts recent gains into context as investors assess how much of the story is already reflected in the share price. Avnet's ability to convert its electronics distribution business...
NYSE:SCHW
NYSE:SCHWCapital Markets

How Schwab’s Dividend Boost and Earnings Upswing Will Impact Charles Schwab (SCHW) Investors

Earlier this week, The Charles Schwab Corporation declared a regular quarterly cash dividend of US$0.32 per common share payable on August 28, 2026, alongside a series of preferred stock dividends scheduled for September 1, 2026. These dividend declarations, together with recently reported higher quarterly net income and earnings per share, highlight Schwab’s current emphasis on returning capital across both common and preferred shareholders. We’ll now examine how Schwab’s stronger quarterly...
NYSE:IVT
NYSE:IVTRetail REITs

InvenTrust Properties (IVT) Looks Fairly Valued Following Dividend Growth Focus

Recent coverage of InvenTrust Properties (IVT) is centering on its pattern of annual dividend increases, a moderate payout ratio, and analyst expectations for earnings growth, all of which are drawing fresh attention from income-focused investors. See our latest analysis for InvenTrust Properties. At a share price of $36.45, InvenTrust Properties has posted a 12.12% 90 day share price return and a 30.74% year to date share price return. The 1 year total shareholder return of 36.62% and 3 year...
NYSE:AI
NYSE:AISoftware

Is C3.ai (AI) Fairly Valued As Lawsuit Relief And Earnings Beat Lift Interest?

C3.ai (AI) is back in focus after a U.S. court dismissed in full a securities class action against the company, and recent results showed revenue and EPS ahead of consensus expectations. See our latest analysis for C3.ai. Despite the legal win and earnings beat, C3.ai’s recent share price return has been weak, with the stock at US$8.15 and down sharply on a year to date and multi year basis. This suggests enthusiasm has cooled even as investors reassess the company’s risk profile. If this...